Medispend

HCP consulting and speaker-program ledger with embedded fair-market-value pricing: for every healthcare-professional engagement the platform holds the needs assessment, the fair-market-value determination and the rate applied, the contract, the delivered activity, the invoice, the payment, and the resulting transparency disclosure — cross-system and cross-market, reconciled end to end. The licensable core is the pricing-and-cadence layer: what a given specialty in a given therapeutic area and country is actually paid per advisory, speaking or consulting engagement, how frequently top consultants are engaged, and how programmes set needs assessment and cadence going forward.

Open buyer room →

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks Medispend and files the sample in your catalog — private to you.

Start 7-day trialNothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry: PharmaceuticalsHealth Care Technology
Instruments: equities
Categories: Alternative

Dataset card

Type: not stated
Format: Tabular structured records across the engagement lifecycle (assessment, fair-market-value determination, contract, activity, invoice, payment, disclosure) spanning multiple markets under governed common definitions, surfaced as governed dashboard and analytic extracts rather than raw system dumps
Volume: No vendor-stated totals. Estimated ~1-10M completed HCP engagement records across the client base to date, each carrying a fair-market-value determination, contract, invoice, payment and disclosure artefact — roughly 5-8 discrete linked records per engagement, hence ~10-80M underlying rows. Basis: client-count and per-programme engagement cadence estimates scaled across the operating life; explicitly an inference, not a vendor figure.
Users: Client-side: an estimated 150-400 enterprise life-sciences client organisations and roughly 5,000-15,000 named user seats, inferred from ~$16.5M revenue at typical enterprise compliance-software contract values across a 190-person company. The population of real interest — healthcare professionals recorded inside client consulting programmes — is not published; realistically in the low hundreds of thousands across the client base.
History: 11 years
Update frequency: not stated
Growth: Active and investing — the article describes an ongoing migration of established customers onto a modern governed analytics foundation, which is capital and engineering investment into an installed base rather than maintenance of a legacy product, and the company remains venture-funded at a 190-person headcount. Read as growth-stage but mid-cycle: expanding capability and global multi-market reach without evidence of a late-stage funding event or rapid headcount scaling.
Launched: ~2014-2016 for the platform as a commercial product. The company record carries a founding-era organizational identifier from mid-2015 plus a venture funding stage, and the firm has operated in the HCP-engagement compliance category long enough for the article to discuss migrating established customers onto a modern analytics foundation — implying a product base predating the current analytics stack.
Delivery: not stated
Entity mapping: not stated
Sample: not stated
Point-in-time: not stated
Licence: not stated

supplier index read from their site